Arcus Biosciences (RCUS) News Today $8.10 -0.84 (-9.34%) Closing price 03:59 PM EasternExtended Trading$7.95 -0.16 (-1.91%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline UpdateMay 6 at 5:47 PM | gurufocus.comArcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline UpdateMay 6 at 4:05 PM | businesswire.comArcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of "Buy" from BrokeragesArcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) has earned an average recommendation of "Buy" from the ten analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation andMay 6 at 2:11 AM | marketbeat.comArcus Biosciences Q1 2025 Earnings PreviewMay 5 at 8:15 PM | msn.comBoxer Capital Management LLC Makes New $23.86 Million Investment in Arcus Biosciences, Inc. (NYSE:RCUS)Boxer Capital Management LLC acquired a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 1,602,200 shares of the company's stock, valued at approximately $23May 4 at 6:25 AM | marketbeat.comPDT Partners LLC Acquires 38,116 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)PDT Partners LLC lifted its holdings in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 43.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 125,752 shares of the company's stock after acquiring an addMay 2, 2025 | marketbeat.comArcus Biosciences (RCUS) Expected to Announce Quarterly Earnings on TuesdayArcus Biosciences (NYSE:RCUS) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-arcus-biosciences-inc-stock/)May 1, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Buys New Stake in Arcus Biosciences, Inc. (NYSE:RCUS)Adage Capital Partners GP L.L.C. bought a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 443,000 shares of the company's stock, valued at approximately $6,596,000. Adage Capital PartnersMay 1, 2025 | marketbeat.comArcus Biosciences, Inc. (NYSE:RCUS) Shares Bought by Invesco Ltd.Invesco Ltd. grew its stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 21.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 203,987 shares of the company's stock after buying an additApril 29, 2025 | marketbeat.comArcus Biosciences, Inc. (NYSE:RCUS) Shares Sold by Decheng Capital LLCDecheng Capital LLC reduced its stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 808,789 shares of the company's stock after selling 61,April 28, 2025 | marketbeat.comArcus Biosciences Announces New Employment Inducement GrantsApril 24, 2025 | businesswire.comDiadema Partners LP Acquires New Shares in Arcus Biosciences, Inc. (NYSE:RCUS)Diadema Partners LP bought a new position in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 165,965 shares of the company's stoApril 24, 2025 | marketbeat.comArcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual MeetingApril 23, 2025 | businesswire.comArcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline UpdateApril 22, 2025 | businesswire.comArcus Biosciences, Inc. (NYSE:RCUS) Shares Sold by Alliancebernstein L.P.Alliancebernstein L.P. trimmed its stake in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 94.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,510 shares of the company's stock after selling 1,228,444 shApril 21, 2025 | marketbeat.comGilead Sciences Inc. Invests $447.61 Million in Arcus Biosciences, Inc. (NYSE:RCUS)Gilead Sciences Inc. purchased a new stake in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 30,061,124 shares of the company's stock,April 20, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Shares Down 5.5% - Time to Sell?Arcus Biosciences (NYSE:RCUS) Stock Price Down 5.5% - Time to Sell?April 16, 2025 | marketbeat.comNorges Bank Buys Shares of 34,044 Arcus Biosciences, Inc. (NYSE:RCUS)Norges Bank purchased a new position in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 34,044 shares of the company's stock, valued at approximately $507,0April 14, 2025 | marketbeat.comExodusPoint Capital Management LP Acquires New Shares in Arcus Biosciences, Inc. (NYSE:RCUS)ExodusPoint Capital Management LP acquired a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 60,193 shares of the company's stock, valued at approximatelyApril 13, 2025 | marketbeat.comVanguard Group Inc. Sells 79,539 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)Vanguard Group Inc. trimmed its position in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,389,216 shares of the company's stock afterApril 13, 2025 | marketbeat.comArcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Recommendation of "Buy" from BrokeragesArcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) has been given a consensus recommendation of "Buy" by the ten research firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation aApril 10, 2025 | marketbeat.comArcus Biosciences Announces New Employment Inducement GrantsApril 9, 2025 | businesswire.comArcus Biosciences Announces New Employment Inducement GrantsApril 9, 2025 | businesswire.comArcus Biosciences (NYSE:RCUS) Reaches New 12-Month Low - What's Next?Arcus Biosciences (NYSE:RCUS) Reaches New 12-Month Low - Time to Sell?April 9, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in Arcus Biosciences, Inc. (NYSE:RCUS)Raymond James Financial Inc. acquired a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 35,662 shares of the compApril 9, 2025 | marketbeat.comArcus Biosciences, Inc. (NYSE:RCUS) Shares Bought by Trexquant Investment LPTrexquant Investment LP boosted its stake in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 241.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 300,548 shares of the company's stock after purchApril 7, 2025 | marketbeat.comArcus Biosciences: A High-Risk Speculation With Multiple Large, Near-Term CatalystsApril 2, 2025 | seekingalpha.comArcus Biosciences (NYSE:RCUS) Hits New 1-Year Low - What's Next?Arcus Biosciences (NYSE:RCUS) Hits New 1-Year Low - Time to Sell?April 1, 2025 | marketbeat.comArcus Biosciences, Inc.'s (NYSE:RCUS) latest 8.6% decline adds to one-year losses, institutional investors may consider drastic measuresMarch 29, 2025 | finance.yahoo.comPrecision BioSciences reports Q4 EPS ($2.22), consensus ($2.94)March 27, 2025 | markets.businessinsider.comArcus Biosciences (NYSE:RCUS) Sets New 12-Month Low - Here's What HappenedArcus Biosciences (NYSE:RCUS) Sets New 1-Year Low - Here's WhyMarch 26, 2025 | marketbeat.comArcus Biosciences management to meet with Cantor FitzgeraldMarch 26, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC) and Lexeo Therapeutics, Inc. (LXEO)March 25, 2025 | markets.businessinsider.comArcus Biosciences Announces New Employment Inducement GrantsMarch 25, 2025 | businesswire.comArcus Biosciences (NYSE:RCUS) Trading 3.6% Higher - Still a Buy?Arcus Biosciences (NYSE:RCUS) Trading 3.6% Higher - What's Next?March 21, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Buys New Shares in Arcus Biosciences, Inc. (NYSE:RCUS)Connor Clark & Lunn Investment Management Ltd. bought a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 64,043 shares of the company's stock, valued atMarch 21, 2025 | marketbeat.com4DTIL : Assessing Precision BioSciences: Insights From 4 Financial AnalystsMarch 19, 2025 | benzinga.comArcus Biosciences (NYSE:RCUS) Shares Gap Down - What's Next?Arcus Biosciences (NYSE:RCUS) Shares Gap Down - Here's WhyMarch 18, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Hits New 12-Month Low - Here's WhyArcus Biosciences (NYSE:RCUS) Reaches New 12-Month Low - Here's WhyMarch 18, 2025 | marketbeat.comBank of New York Mellon Corp Has $5.68 Million Position in Arcus Biosciences, Inc. (NYSE:RCUS)Bank of New York Mellon Corp lifted its holdings in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 381,615 shares of the company's stock after purchasing an additional 30,290 shares durMarch 17, 2025 | marketbeat.comArcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Recommendation of "Buy" by AnalystsShares of Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) have received an average rating of "Buy" from the ten brokerages that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, eight have issued a buyMarch 16, 2025 | marketbeat.comArcus Biosciences at Barclays Conference: Strategic Pipeline InsightsMarch 15, 2025 | uk.investing.comArcus Biosciences, Inc. (RCUS): Among Top Insider Purchases Last MonthMarch 14, 2025 | msn.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), aTyr Pharma (ATYR) and Lyra Therapeutics (LYRA)March 14, 2025 | markets.businessinsider.comCantor Fitzgerald Has Positive View of RCUS FY2025 EarningsArcus Biosciences, Inc. (NYSE:RCUS - Free Report) - Research analysts at Cantor Fitzgerald upped their FY2025 earnings estimates for Arcus Biosciences in a note issued to investors on Tuesday, March 11th. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will post earnings of ($3March 14, 2025 | marketbeat.com2seventy bio (TSVT) was downgraded to a Hold Rating at Leerink PartnersMarch 11, 2025 | markets.businessinsider.comArcus Biosciences (NYSE:RCUS) Reaches New 52-Week Low - Should You Sell?Arcus Biosciences (NYSE:RCUS) Reaches New 52-Week Low - Here's What HappenedMarch 11, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Sets New 52-Week Low - Time to Sell?Arcus Biosciences (NYSE:RCUS) Reaches New 1-Year Low - What's Next?March 6, 2025 | marketbeat.comArcus Biosciences (RCUS): Among Stocks With At Least $10 Million In Insider Spending RecentlyMarch 5, 2025 | insidermonkey.comArcus Biosciences (NYSE:RCUS) Stock Price Down 5.8% - Here's What HappenedArcus Biosciences (NYSE:RCUS) Shares Down 5.8% - Here's WhyMarch 5, 2025 | marketbeat.com Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address RCUS Media Mentions By Week RCUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCUS News Sentiment▼1.330.69▲Average Medical News Sentiment RCUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCUS Articles This Week▼76▲RCUS Articles Average Week Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ultragenyx Pharmaceutical News Today Akero Therapeutics News Today Arcellx News Today SpringWorks Therapeutics News Today Zai Lab News Today Viking Therapeutics News Today PTC Therapeutics News Today Crinetics Pharmaceuticals News Today Scholar Rock News Today Merus News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RCUS) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...Crypto 101 Media | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCUS Stock Free RCUS Stock Alerts